Table 4.
Factors potentially associated with neonatal hypertension
| Covariate | Unadjusted OR | Adjusted OR | P valuea |
|---|---|---|---|
| Sulindac duration, days | 0.99 (0.95‐1.04) | 0.94 (0.86‐1.03) | 0.164 |
| Indomethacin duration, days | 1.11 (1.00‐1.22) | 1.17 (1.00‐1.38) | 0.055 |
| Doses of antenatal steroids | 1.35 (0.94‐1.94) | 1.34 (0.90‐1.98) | 0.147 |
| Calcium channel blockers | 0.68 (0.27‐1.68) | 0.50 (0.18‐1.41) | 0.191 |
| Maternal race (Caucasian) | 0.91 (0.43‐1.91) | 0.87 (0.39‐1.94) | 0.739 |
| Infant sex (male) | 1.17 (0.57‐2.38) | 1.15 (0.54‐2.44) | 0.725 |
| GA at birth | 0.86 (0.75‐0.98) | 0.89 (0.77‐1.02) | 0.092 |
Adjusted for all covariates listed in table.
P value for adjusted OR.